Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue 4, 2006, Pages 401-404

  Djomand, Gaston ^a   Duerr, Ann ^a   Faulhaber, José Cláudio ^b   Struchiner, Claudio J ^c   Pacheco, A Guilherme ^c   Barroso, Paulo F ^b   Melo, M Fatima ^b   Schechter, Mauro ^b  

^a HIV Vaccine Trials Network   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Brazil; High risk; HIV seroconversion; Men who have sex with men

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BISEXUALITY; BRAZIL; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DEVELOPING COUNTRY; FOLLOW UP; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; VIROLOGY; VIRUS LOAD;

ADULT; BISEXUALITY; BRAZIL; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HOMOSEXUALITY; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL LOAD;

EID: 33750957756     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000243117.21788.90     Document Type: Article

References (20)

1. Morgado MG, Sabino EC, Shpaer EG, et al. V3 region polymorphisms in HIV-1 form Brazil: prevalence of subtype B strains divergent from North American/European prototype and detection of subtype F. AIDS Res Hum Retroviruses. 1994;10:569-576.
2. Santoro-Lopes G, Harrison LH, Tavares MD, et al. HIV disease progression and V3 serotypes in Brazil: Is B different from B-Br? AIDS Res Hum Retroviruses. 2000;16:953-958.
3. Perisse AR, Schechter M, Moreira RI, et al. Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praca Onze Study Group. J Acquir Immune Defic Syndr. 2000;25:459-463.
4. Giorgi JV, Lyles RH, Matud JL, et al. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr. 2002;29:346-355.
5. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341:394-402.
6. Gilbert PB, DeGruttola VG, Hudgens MG, et al. What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials. J Infect Dis. 2003;188:179-193.
7. Lyles RH, Munoz A, Yamashita TE, et al. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis. 2000;181:872-880.
8. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet. 2000;355:1131-1137.
9. UNAIDS and WHO. AIDS Epidemic Update. Geneva; 2004; UNAIDS/04.45E.
10. Schechter M, do Lago RF, Mendelsohn AB, et al. Behavioral impact, acceptability, and HIV incidence among homosexual men with access to postexposure chemoprophylaxis for HIV. Praca Onze Study Team. J Acquir Immune Defic Syndr. 2004;35:519-525.
11. Frank E. Harrell Jr. with contributions from many other users. Hmisc: Harrell Miscellaneous. R package version 3.0-12. 2006. Available at: http://biostat.mc.vanderbilt.edu/s/Hmisc, http://biostat.mc.vanderbilt.edu/ twiki/pub/main/RS/sintro.pdf, and http://biostat.mc.vanderbilt.edu/twiki/pub/ main/StatReport/summary.pdf.
12. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing. 2006. Available at: http://www.R-project.org.
13. Rinke de Wit TF, Tsegaye A, Wolday D, et al. Primary HIV-1 subtype C infection in Ethiopia. J Acquir Immune Defic Syndr. 2002;30:463-470.
14. Rangsin R, Chiu J, Khamboonruang C, et al. The Natural History of HIV-1 Infection in Young Thai Men After Seroconversion. J Acquir Immune Defic Syndr. 2004;36:622-629.
15. Mehendale SM, Bollinger RC, Kulkarni SS, et al. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India. AIDS Res Hum Retroviruses. 2002;18:1175-1179.
16. Kanki PJ, Hamel DJ, Sankale JL, et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999;179:68-73.
17. Hu DJ, Vanichseni S, Mastro TD, et al. Viral load differences in early infection with two HIV-1 subtypes. AIDS. 2001;15:683-691.
18. Salamon R, Marimoutou C, Ekra D, et al. Clinical and biological evolution of HIV-1 seroconverters in Abidjan, Cote d'Ivoire, 1997-2000. J Acquir Immune Defic Syndr. 2002;29:149-157.
19. Katubulushi M, Zulu I, Yavwa F, et al. Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia. AIDS. 2005;19:102-103.
20. Urassa W, Bakari M, Sandstrom E, et al. Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS. 2004;18:433-438.